Primary objective of study of sitagliptin in patients with ESRD on dialysis.

MLA

Arjona Ferreira, J. C., et al. “Primary Objective of Study of Sitagliptin in Patients with ESRD on Dialysis.” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, vol. 62, no. 3, Sept. 2013, p. 642. EBSCOhost, https://doi.org/10.1053/j.ajkd.2013.05.026.

APA

Arjona Ferreira, J. C., Golm, G. T., & Goldstein, B. J. (2013). Primary objective of study of sitagliptin in patients with ESRD on dialysis. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, 62(3), 642. https://doi.org/10.1053/j.ajkd.2013.05.026

Chicago

Arjona Ferreira, J C, G T Golm, and B J Goldstein. 2013. “Primary Objective of Study of Sitagliptin in Patients with ESRD on Dialysis.” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 62 (3): 642. doi:10.1053/j.ajkd.2013.05.026.